Elucidating the elite: mechanisms of control in HIV-1 infection

被引:88
作者
O'Connell, Karen A. [1 ]
Bailey, Justin R. [1 ]
Blankson, Joel N. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; LONG-TERM NONPROGRESSORS; NATURAL-KILLER-CELLS; LOW-LEVEL VIREMIA; DISEASE PROGRESSION; TYPE-1; INFECTION; NEUTRALIZING ANTIBODIES; VIRAL SUPPRESSION;
D O I
10.1016/j.tips.2009.09.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In patients with progressive disease, untreated HIV-1 infection is characterized by high viral loads and decreasing CD4(+)T cell counts which lead to opportunistic infection and other AIDS-defining illness. A rare subset of patients termed' elite controllers' (ECs) maintain control over viremia and often retain normal CD4(+)T cell levels without treatment with antiretroviral drugs. For the most part these patients are infected with replication-competent, fit virus. Factors such as strong, polyfunctional cytotoxic T lymphocyte (CTL) responses and retention of T cell proliferative ability appear to be important in control of HIV-1. Defining what enables ECs to control viral replication will aid in the development of effective vaccine and treatment regimens. This review will discuss differences between ECs and progressors while emphasizing recent findings on the immunological response of ECs to HIV-1.
引用
收藏
页码:631 / 637
页数:7
相关论文
共 80 条
  • [1] Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection
    Alexander, L
    Weiskopf, E
    Greenough, TC
    Gaddis, NC
    Auerbach, MR
    Malim, MH
    O'Brien, SJ
    Walker, BD
    Sullivan, JL
    Desrosiers, RC
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (09) : 4361 - 4376
  • [2] Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
    Almeida, Jorge R.
    Price, David A.
    Papagno, Laura
    Arkoub, Zaina Ait
    Sauce, Delphine
    Bornstein, Ethan
    Asher, Tedi E.
    Samri, Assia
    Schnuriger, Aurelie
    Theodorou, Ioannis
    Costagliola, Dominique
    Rouzioux, Christine
    Agut, Henri
    Marcelin, Anne-Genevieve
    Douek, Daniel
    Autran, Brigitte
    Appay, Victor
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (10) : 2473 - 2485
  • [3] NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection
    Alter, G.
    Altfeld, M.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2009, 265 (01) : 29 - 42
  • [4] Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection
    Altfeld, M
    Addo, MA
    Rosenberg, ES
    Hecht, FA
    Lee, PK
    Vogel, M
    Yu, XG
    Draenert, R
    Johnston, MN
    Strick, D
    Allen, TA
    Feeney, ME
    Kahn, JO
    Sekaly, RP
    Levy, JA
    Rockstroh, JK
    Goulder, PJR
    Walker, BD
    [J]. AIDS, 2003, 17 (18) : 2581 - 2591
  • [5] CD4+ T cell depletion in an untreated HIV type1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load
    Andrade, Adriana
    Bailey, Justin R.
    Xu, Jie
    Philp, Frances H.
    Quinn, Thomas C.
    Williams, Thomas M.
    Ray, Stuart C.
    Thomas, David L.
    Blankson, Joel N.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) : E78 - E82
  • [6] BAILEY JR, 2008, J VIROL
  • [7] Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape
    Bailey, Justin R.
    Zhang, Haili
    Wegweiser, Barbara W.
    Yang, Hung-Chih
    Herrera, Laura
    Ahonkhai, Aima
    Williams, Thomas M.
    Siliciano, Robert F.
    Blankson, Joel N.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (01) : 50 - 55
  • [8] Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations
    Bailey, Justin R.
    Williams, Thomas M.
    Siliciano, Robert F.
    Blankson, Joel N.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (05) : 1357 - 1369
  • [9] Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy
    Bailey, Justin R.
    Lassen, Kara G.
    Yang, Hung-Chih
    Quinn, Thomas C.
    Ray, Stuart C.
    Blankson, Joel N.
    Siliciano, Robert F.
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (10) : 4758 - 4770
  • [10] Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy
    Barker, Edward
    Martinson, Jeff
    Brooks, Cicely
    Landay, Alan
    Deeks, Steven
    [J]. AIDS, 2007, 21 (17) : 2363 - 2365